HCA Healthcare, Inc. (NYSE:HCA) Holdings Trimmed by Meeder Asset Management Inc.

Meeder Asset Management Inc. reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 98.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 406 shares of the company's stock after selling 34,117 shares during the quarter. Meeder Asset Management Inc.'s holdings in HCA Healthcare were worth $122,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Norges Bank acquired a new stake in shares of HCA Healthcare in the 4th quarter worth approximately $840,286,000. Royal London Asset Management Ltd. grew its holdings in HCA Healthcare by 62.0% in the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock valued at $450,461,000 after purchasing an additional 574,239 shares during the last quarter. Principal Financial Group Inc. raised its stake in shares of HCA Healthcare by 120.1% during the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock worth $262,264,000 after buying an additional 476,756 shares during the last quarter. Meritage Group LP acquired a new stake in HCA Healthcare in the 3rd quarter valued at about $150,548,000. Finally, Raymond James Financial Inc. purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at about $74,121,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.30% of the company's stock.

Remove Ads

Analyst Ratings Changes

HCA has been the topic of a number of recent research reports. Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Bank of America decreased their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, Morgan Stanley dropped their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $385.67.

HCA Healthcare Stock Performance

HCA traded down $16.61 during trading on Friday, reaching $332.53. 2,518,277 shares of the company were exchanged, compared to its average volume of 1,364,360. The stock has a market cap of $81.87 billion, a P/E ratio of 15.14, a PEG ratio of 1.10 and a beta of 1.68. The firm has a 50 day moving average of $327.23 and a 200 day moving average of $339.04. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the firm earned $5.90 earnings per share. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.87%. HCA Healthcare's dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.